Johnson & Johnson Receives Positive CHMP Opinion Recommending Full Approval For Sirturo For Treatment Of Multidrug-Resistant Tuberculosis
Johnson & Johnson Receives Positive CHMP Opinion Recommending Full Approval For Sirturo For Treatment Of Multidrug-Resistant Tuberculosis
強生收到CHMP的積極意見，建議全面批准Sirturo用於治療耐多藥結核病
Johnson & Johnson Receives Positive CHMP Opinion Recommending Full Approval For Sirturo For Treatment Of Multidrug-Resistant Tuberculosis
強生收到CHMP的積極意見，建議全面批准Sirturo用於治療耐多藥結核病
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。